Edmond, OK, United States of America

Richard E Gammans

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 48(Granted Patents)


Location History:

  • Vass, NC (US) (2012)
  • Edmond, OK (US) (2015 - 2024)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Richard E. Gammans

Introduction

Richard E. Gammans is a notable inventor based in Edmond, Oklahoma. He has made significant contributions to the field of medicine, particularly in the treatment of progressive neurodegenerative diseases. With a total of seven patents to his name, Gammans has demonstrated a commitment to advancing healthcare through innovative solutions.

Latest Patents

Among his latest patents is a groundbreaking treatment for progressive neurodegenerative diseases using ibudilast. This patent focuses on compositions and methods for treating these diseases and their associated symptoms through the administration of ibudilast, specifically the compound 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine. This innovative approach highlights Gammans' dedication to finding effective therapies for challenging medical conditions.

Career Highlights

Throughout his career, Richard E. Gammans has worked with several prominent companies, including Medicinova, Inc. and Otologic Pharmaceuticals, Inc. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to the development of new medical treatments.

Collaborations

Gammans has had the opportunity to work alongside notable colleagues such as Michael E. Kalafer and Kenneth Walter Locke. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Richard E. Gammans is a distinguished inventor whose work in the treatment of progressive neurodegenerative diseases has the potential to change lives. His innovative patents and collaborations reflect his dedication to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…